MD-reviewed ·  Healthcare editorial
MedAI Verdict
Surgical AI

Reference AS-022  ·  AI Surgical Tools

Asensus Surgical ISU

by Asensus Surgical

Senhance robotic platform with Intelligent Surgical Unit (ISU).

Visit Asensus Surgical ISURead our methodology

At a glance

Pricing
Enterprise capital.
HIPAA
Not disclosed
SOC 2
Not disclosed
EHRs
—
Founded
—

Independent score  ·  By our public rubric

5/100Tracked
How it’s computed →
  • Regulatory & Compliance
    0/28

    No FDA clearance listed

  • Clinical Integration
    0/26

    No EHR integrations listed

  • Evidence Strength
    0/28.8

    No peer-reviewed coverage

  • Vendor & Market
    3/18

    market_relevance=50 (seed or unfunded)

  • Sentiment & Transparency
    2.5/14

    1 pricing tier(s) but no $ amounts (contact-sales pattern)

▸ Show all 11 dimensions

Regulatory & Compliance

  • FDA clearance0/18

    No FDA clearance listed

  • HIPAA / SOC2 / BAA0/10

    No public HIPAA/SOC2/BAA attestation

Clinical Integration

  • EHR integrations (count)0/14

    No EHR integrations listed

  • Top-3 EHR coverage (Epic / Oracle / Athena)0/8

    None of the top-3 EHRs covered

  • Bidirectional write-back0/4

    No bidirectional write-back documented

Evidence Strength

  • Peer-reviewed papers0/21

    No peer-reviewed coverage

  • RCT / meta-analysis / systematic review0/8

    No RCT, meta-analysis, or systematic review

Vendor & Market

  • Funding & adoption signal3/12

    market_relevance=50 (seed or unfunded)

  • Years in market0/6

    Founded year not recorded

Sentiment & Transparency

  • Clinician sentiment (Reddit)0/9

    No clinician sentiment data available

  • Pricing transparency3/5

    1 pricing tier(s) but no $ amounts (contact-sales pattern)

Last computed May 26, 2026 · Rubric v1.0.0

Bottom line

Senhance robotic platform with Intelligent Surgical Unit (ISU).

Free tier available.

Editorial review pending

We do not yet have enough independent sources for Asensus Surgical ISU to publish a full editorial review. A complete review requires peer-reviewed coverage, clinician sentiment from public forums, or hands-on testing notes from our editorial team.

The vendor overview below reflects what we have verified from the vendor and from our category-level reporting. When additional sources surface, the review is regenerated automatically and dated. If you have direct hands-on experience and want to share it on the record, write to editorial@medaiverdict.com.

Overview

NYSE:ASXC. Senhance robotic platform + ISU AI assistant.

Pricing

What it costs

Free tier only; no paid plans publicly disclosed.

TierMonthlyAnnualNotes
Plan——Enterprise capital.

Source: vendor pricing page. Verified July 3, 2026.

In the same category

Other surgical ai

See the full surgical ai ranking